AT306930B - Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen - Google Patents

Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen

Info

Publication number
AT306930B
AT306930B AT439269A AT439269A AT306930B AT 306930 B AT306930 B AT 306930B AT 439269 A AT439269 A AT 439269A AT 439269 A AT439269 A AT 439269A AT 306930 B AT306930 B AT 306930B
Authority
AT
Austria
Prior art keywords
azacytosines
glycosyl
preparation
Prior art date
Application number
AT439269A
Other languages
English (en)
Inventor
Alois Piskala
Frantisek Sorm
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Application granted granted Critical
Publication of AT306930B publication Critical patent/AT306930B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12Triazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT439269A 1968-05-08 1969-05-07 Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen AT306930B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS339968 1968-05-08

Publications (1)

Publication Number Publication Date
AT306930B true AT306930B (de) 1973-04-25

Family

ID=5373920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT439269A AT306930B (de) 1968-05-08 1969-05-07 Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen

Country Status (12)

Country Link
JP (1) JPS4916435B1 (de)
AT (1) AT306930B (de)
BE (1) BE732268A (de)
BR (1) BR6908600D0 (de)
CA (1) CA921904A (de)
CH (1) CH527207A (de)
DE (1) DE1922702A1 (de)
ES (1) ES366910A1 (de)
FR (1) FR2008048A1 (de)
GB (1) GB1227691A (de)
IT (1) IT1037009B (de)
NL (1) NL6906909A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2012888C3 (de) * 1970-03-14 1981-04-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden
US6905669B2 (en) 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US6887855B2 (en) 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US20060014949A1 (en) * 2004-07-13 2006-01-19 Supergen Inc. Compositions and formulations of decitabine polymorphs and methods of use thereof
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2073807A1 (de) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmazeutische kombinationen
PT3782611T (pt) 2008-05-15 2022-11-18 Celgene Corp Formulações orais de análogos da citidina e métodos de utilização dos mesmos
JP5650643B2 (ja) 2008-08-08 2015-01-07 サイノファーム タイワン リミテッド 5−アザシトシンヌクレオシド及びその誘導体の製造方法
BR112013025167A2 (pt) 2011-03-31 2019-09-24 Celgene Int Sarl processo para preparar 5-azacitidina, ou um sal, solvato, hidrato, ou seu polimorfo, sal de 5-azacitidina, 5-azacitidina, ou um sal, solvato, hidrato, ou polimorfo
EP2750768B1 (de) 2011-08-30 2018-10-03 Astex Pharmaceuticals, Inc. Decitabin-derivat zubereitungen
KR20180024010A (ko) 2015-07-02 2018-03-07 오쓰까 세이야꾸 가부시키가이샤 동결건조된 약제학적 조성물
WO2017090264A1 (ja) 2015-11-27 2017-06-01 大原薬品工業株式会社 5-アザシチジン又は其の2'-デオキシ体の5'位ジベンジル燐酸エステル
WO2017183215A1 (ja) 2016-04-21 2017-10-26 大原薬品工業株式会社 5-アザシチジン類の糖部シリルエーテル誘導体
JP6162349B1 (ja) 2016-04-21 2017-07-12 大原薬品工業株式会社 5−アザシチジン類の糖部シリルエーテル誘導体
US10227374B2 (en) 2016-04-21 2019-03-12 Ohara Pharmaceutical Co., Ltd. Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety
EP3661522A2 (de) 2017-08-03 2020-06-10 Otsuka Pharmaceutical Co., Ltd. Arzneimittelverbindung und reinigungsverfahren dafür
US20220332737A1 (en) * 2019-06-07 2022-10-20 Ludwig-Maximilians-Universität München Carbocyclic nucleoside analogue

Also Published As

Publication number Publication date
FR2008048A1 (de) 1970-01-16
ES366910A1 (es) 1971-03-16
IT1037009B (it) 1979-11-10
CA921904A (en) 1973-02-27
DE1922702A1 (de) 1969-11-20
CH527207A (de) 1972-08-31
GB1227691A (de) 1971-04-07
JPS4916435B1 (de) 1974-04-22
BE732268A (de) 1969-10-01
BR6908600D0 (pt) 1973-02-22
NL6906909A (de) 1969-11-11

Similar Documents

Publication Publication Date Title
CH507249A (de) Verfahren zur Herstellung von 2-Brom-a-ergokryptin
AT306930B (de) Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen
AT291254B (de) Verfahren zur herstellung von 3-amino-4jod-5-methyllisoxazolen
AT296964B (de) Verfahren zur Herstellung von 1-Hydroxyphenyl-2-aminoäthanolen
CH501573A (de) Verfahren zur Herstellung von Trimethyl-p-benzochinon
AT294064B (de) Verfahren zur Herstellung von 1-Alkyl-2-aminomethylpyrrolidinen
CH520135A (de) Verfahren zur Herstellung von Erythromycylamin
CH516529A (de) Verfahren zur Herstellung von 4-Cyano-4-phenyl-aminocyclohexanen
AT296254B (de) Verfahren zur Herstellung von 2-Acyloxythionobenzamiden
CH486444A (de) Verfahren zur Herstellung von 7-Cyan-cumarinen
CH513141A (de) Verfahren zur Herstellung von Glyoxaldithiosemicarbazonen
CH520672A (de) Verfahren zur Herstellung von Chlorfluorpyridinen
AT314097B (de) Verfahren zur Herstellung von 19-Norsteroiden
AT286252B (de) Verfahren zur Herstellung von 3-Aminopropanolen
AT292205B (de) Verfahren zur Herstellung von 1-Peracylglykosyl-5-azacytosinen
AT289737B (de) Verfahren zur Herstellung von Sulfatobetainen
CH517703A (de) Verfahren zur Herstellung von Glycyl-L-tryptophyl-L-methionyl-glycinamiden
AT296251B (de) Verfahren zur Herstellung von Methylcyclohexenen
AT290555B (de) Verfahren zur Herstellung von Triorganosilanolen
CH517758A (de) Verfahren zur Herstellung von 1-Pyridyl-2-imidazolonen
CH518290A (de) Verfahren zur Herstellung von Hydroxyphenazin-di-N-oxiden
AT291577B (de) Verfahren zur Herstellung von Polyacyloxamidrazonen
CH521333A (de) Verfahren zur Herstellung von 9a-Fluor-16-methylen-prednisolon-21-acetat
CH514524A (de) Verfahren zur Herstellung von Cyclopent-2-enyl-phenolen
CH487927A (de) Verfahren zur Herstellung von 7-Triazolyl-cumarinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee